ES2001636A6 - Metodo para determinar un analito que se fija al "receptor molecular" representado por d-alanil -d-alanina, soporte analitico y estuche analitico para dicho metodo. - Google Patents

Metodo para determinar un analito que se fija al "receptor molecular" representado por d-alanil -d-alanina, soporte analitico y estuche analitico para dicho metodo.

Info

Publication number
ES2001636A6
ES2001636A6 ES8601560A ES8601560A ES2001636A6 ES 2001636 A6 ES2001636 A6 ES 2001636A6 ES 8601560 A ES8601560 A ES 8601560A ES 8601560 A ES8601560 A ES 8601560A ES 2001636 A6 ES2001636 A6 ES 2001636A6
Authority
ES
Spain
Prior art keywords
analytical
alanine
alanil
analyte
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8601560A
Other languages
English (en)
Inventor
Angelo Corti
Angelo Borghi
Carlo Rurali
Giovanni Cassani
Francesco Parenti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of ES2001636A6 publication Critical patent/ES2001636A6/es
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446Antibacterials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545Synthetic resin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analyzing Materials Using Thermal Means (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

METODO PARA DETERMINAR UN ANALITO QUE SE FIJA AL <RECEPTOR MOLECULAR> REPRESENTADO POR D-ALANIL-D-ALANINA, SOPORTE ANALITICO Y ESTUCHE ANALITICO PARA DICHO METODO, EN DONDE SE PONE EN CONTACTO UNA SOLUCION DE ENSAYO CON UNA SUPERFICIE QUE LLEVA UN OLIGOPEPTIDO DEL TIPO ANTES MENCIONADO CONJUGADO CON UN VEHICULO MACROMOLECULAR, SE ENJUAGA, SE AÑADEN ANTICUERPOS ESPECIFICOS CONTRA LA SUSTANCIA A DETECTAR Y SE REVELAN DICHOS ANTICUERPOS FIJADOS AL ANTIGENO EN LA FASE ESTACIONARIA POR MEDIO DE UN ANTICUERPO ANTI-IGG. EL INVENTO ES ESPECIALMENTE UTIL PARA DETERMINAR ANTIBIOTICOS GLICOPEPTIDICOS DE LA CLASE DE LA VANCOMICINA.
ES8601560A 1985-09-10 1986-09-02 Metodo para determinar un analito que se fija al "receptor molecular" representado por d-alanil -d-alanina, soporte analitico y estuche analitico para dicho metodo. Expired ES2001636A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858522388A GB8522388D0 (en) 1985-09-10 1985-09-10 Receptor-antibody sandwich assay

Publications (1)

Publication Number Publication Date
ES2001636A6 true ES2001636A6 (es) 1988-06-01

Family

ID=10584952

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8601560A Expired ES2001636A6 (es) 1985-09-10 1986-09-02 Metodo para determinar un analito que se fija al "receptor molecular" representado por d-alanil -d-alanina, soporte analitico y estuche analitico para dicho metodo.

Country Status (20)

Country Link
EP (1) EP0221282B1 (es)
JP (1) JPS6271860A (es)
KR (1) KR870003386A (es)
CN (1) CN86105930A (es)
AT (1) ATE64997T1 (es)
AU (1) AU600446B2 (es)
CA (1) CA1276880C (es)
DE (1) DE3680072D1 (es)
DK (1) DK165075C (es)
ES (1) ES2001636A6 (es)
FI (1) FI82987C (es)
GB (1) GB8522388D0 (es)
GR (1) GR862271B (es)
HU (1) HU201608B (es)
IL (1) IL79924A0 (es)
NO (1) NO167421C (es)
NZ (1) NZ217502A (es)
PH (1) PH26235A (es)
PT (1) PT83299B (es)
ZA (1) ZA866643B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198340A (en) * 1991-01-17 1993-03-30 Genentech, Inc. Assay for free igf-i, igf-ii, and gh levels in body fluids
CA2216880A1 (en) * 1995-04-04 1996-10-10 Abbott Laboratories Reagents and methods for the detection and quantification of vancomycin in biological fluids
US6797479B2 (en) 1995-04-04 2004-09-28 Abbott Laboratories Reagents and methods for the detection and quantification of vancomycin in biological fluids
KR100505783B1 (ko) * 2001-12-27 2005-08-03 근화제약주식회사 항생제 테이코플라닌의 면역분석 방법
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
US10627393B2 (en) 2012-07-31 2020-04-21 Sekisui Medical Co., Ltd. Latex agglutination inhibition immunoassay
WO2020171158A1 (ja) * 2019-02-20 2020-08-27 株式会社パートナーファーム 固相反応チップ及びこれを用いた測定方法
CN116396401B (zh) * 2023-03-07 2025-09-26 浙江准策生物技术有限公司 替考拉宁完全抗原和抗体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034074A (en) * 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US4410634A (en) * 1979-10-26 1983-10-18 Dynasciences Corporation Method of passively adsorbing immuno-reactive haptens to solid phases
US4606855A (en) * 1982-07-26 1986-08-19 Mex Research Associates C/O Leon Reimer Monoclonal antibody to digoxin
US4558009A (en) * 1982-12-20 1985-12-10 Eli Lilly And Company Process for producing antibiotic A-51568 by fermentation and microorganism
GB8311136D0 (en) * 1983-04-25 1983-06-02 Lepetit Spa Immobilised oligopeptides
GB8427436D0 (en) * 1984-10-30 1984-12-05 Lepetit Spa Receptor assay

Also Published As

Publication number Publication date
NZ217502A (en) 1989-08-29
EP0221282B1 (en) 1991-07-03
ZA866643B (en) 1987-04-29
GR862271B (en) 1986-12-31
PT83299A (pt) 1986-10-01
PT83299B (pt) 1988-07-29
AU6232186A (en) 1987-03-12
FI82987C (fi) 1991-05-10
EP0221282A2 (en) 1987-05-13
FI863637L (fi) 1987-03-11
PH26235A (en) 1992-04-01
EP0221282A3 (en) 1987-08-05
KR870003386A (ko) 1987-04-17
NO863493D0 (no) 1986-09-01
GB8522388D0 (en) 1985-10-16
ATE64997T1 (de) 1991-07-15
DK429386D0 (da) 1986-09-09
CA1276880C (en) 1990-11-27
JPS6271860A (ja) 1987-04-02
HU201608B (en) 1990-11-28
DK165075C (da) 1993-02-22
FI82987B (fi) 1991-01-31
AU600446B2 (en) 1990-08-16
FI863637A0 (fi) 1986-09-10
DE3680072D1 (de) 1991-08-08
DK165075B (da) 1992-10-05
NO167421B (no) 1991-07-22
NO863493L (no) 1987-03-11
IL79924A0 (en) 1986-12-31
NO167421C (no) 1991-10-30
DK429386A (da) 1987-03-11
HUT41904A (en) 1987-05-28
CN86105930A (zh) 1987-03-11

Similar Documents

Publication Publication Date Title
DK261386A (da) Monoklonale antistoffer
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
DE68929334D1 (de) Verfahren zumm Assay von Endotoxin-Konzentration
ATE64997T1 (de) Rezeptor-antikoerper-sandwich-untersuchung.
KR930700548A (ko) 자궁내막 항체 측정방법 및 측정용 자궁내막 항원, 조성물, 테스트킷
AU2489597A (en) A method for measuring antigen concentration
FI905350A7 (fi) Leimattua streptokokki-vasta-ainetta sisältävä koostumus, testipakkaus ja analyysimenetelmä, jossa sitä käytetään
ATE270345T1 (de) Nukleinsaeure erkennung von hepatitis gb virus
ATE45042T1 (de) Festphasenempfaengeranalyse fuer antibiotika der vancomycinklasse.
DK1423708T3 (da) Sammensætninger og fremgangsmåder til bestemmelser af AA4RP
IT8906606A0 (it) Test immunoenzimatico per la ricerca e determinazione degli anticorpi anticaseina bovina nel siero

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000208